CpG oligodeoxynucleotides (or CpG ODNs)

 

DNA molecules that contain an unmethylated CG (Cytosine-guanine) di nucleotide in a specific base sequence (CpG motifs). The p refers to the phosphodiester backbone. CpG oligodeoxynucleotides (ODNs) represent a novel pharmacotherapeutic class with profound immunomodulatory properties.


.....Read More.

 

Catalog# Product Description Product Type Size
ATODN1-1AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen gradeODNs/DNAs100 ug
ATODN2-1AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen gradeODNs/DNAs100 ug
ATODN3-1AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen gradeODNs/DNAs100 ug
AV-1015-10Adjuphos® aluminum phosphate (Th2) Vaccine adjuvant, FDA ApprovedODNs/DNAs10 ml
AV-1015-50Adjuphos® aluminum phosphate (Th2) Vaccine adjuvant, FDA ApprovedODNs/DNAs50 ml
AV-1020-100Calcium phosphate vaccine adjuvantAdjuvant100 ml
AV-2000-PK-1PLGA Combo Trial Pak-1 (Contains 100 mg each of AV-2010-1; AV-2020-1 and AV-2030-1)Adjuvant1 pk
AV-2010-1PLGA poly(lactic-co-glycolic) acid); synthetic; (50% lactic and 50% glycolic acid, ~30-60 Kda)ODNs/DNAs0.1 g
AV-2020-1PLGA poly(lactic-co-glycolic) acid); synthetic; (65% lactic and 35% glycolic acid, ~ 40-75 Kda)Adjuvant1 g
AV-2030-1PLGA poly(lactic-co-glycolic) acid); synthetic; (75% lactic and 25% glycolic acid, ~ 65-105 Kda)ODNs/DNAs1 g
AV-2040-1PLGA poly(lactic-co-glycolic) acid); synthetic (75% lactic and 25% glycolic acid; Ester capped, , MW 75-115 Kda)ODNs/DNAs1 g
AV-2050-1Poly(lactide-co-glycolide) star, glucose core, hydroxyl terminated vaccine adjuvantODNs/DNAs0.1 g
AV-2060-1Poly(lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly(lactide-co-glycolide)Adjuvant1 g
AV-2070-1Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide)ODNs/DNAs0.1 g
AV-3000-PK-1Classical Adjuvant Combo Pak-1 (contains 10 ml each CFA (#AV-3010-10); IFA (AV-3015-10), and Squalene (#AV-3020-10)Adjuvant1 pk
AV-3010-10Complete Freund?s Adjuvant (CFA);vaccine adjuvantAdjuvant10 ml
AV-3010-100Complete Freund?s Adjuvant (CFA);vaccine adjuvantAdjuvant10x10 ml
AV-3015-10Incomplete Freund?s Adjuvant (IFA);vaccine adjuvantAdjuvant10 ml
AV-3015-100Incomplete Freund?s Adjuvant (IFA);vaccine adjuvantAdjuvant10x10 ml
AV-3020-10Squalene (oil-in-water nano emulsion);vaccine adjuvantAdjuvant10 ml
AV-4000-PK-1Saponins vaccine adjuvant Combo Pak-1 (contains 1mg of QS21,100 mg of Vet-SAP and 1 g of Saponin).Adjuvant1 pk
AV-4010-1QS-21 (Quillaja saponaria), Vaccine adjuvant, (EU GMP grade) >95%Adjuvant1 mg
AV-4010-5QS-21 (Quillaja saponaria), Vaccine adjuvant, (EU GMP grade) >95%Adjuvant5 mg
AV-4020-100Vet-SAP Vaccine adjuvant, (EU GMP grade) >95%;Adjuvant100 mg
AV-4020-1000Vet-SAP Vaccine adjuvant, (EU GMP grade) >95%;Adjuvant1 g
AV-4030-10Saponin (Quillaja bark) pure, (sapogenin 25-35%)Adjuvant10 g
AV-4031-10Saponin (Quillaja bark) pure, (sapogenin =10%)Adjuvant10 g
AV-5000-PK-1Oil Adjuvant Combo Pak-1 (Contains 10 ml Peanut Oil (#AV-5010-10); Mineral oil (#AV-5020-10) and 1 g Mannide monooleate (#AV-5030-1)Adjuvant1 pk
AV-5010-50Peanut Oil vaccine adjuvantAdjuvant50 ml
AV-5020-50Mineral Oil vaccine adjuvantAdjuvant50 ml
AV-5030-5Mannide monooleate vaccine adjuvantAdjuvant5 g
AV-6010-100HS15 Kolliphore vaccine adjuvantAdjuvant100 g
AV-7000-PK-1LPS/MPLA/MDP vaccine adjuvant Combo Pak-1 (contains 1 mg each of LPS (#AV-7015-1), MPLA-SM (#AV-7025-1) and MDP (#AV-7035-1);Adjuvant1 pk
AV-7010-50Recombinant flagellin FlicC vaccine adjuvant (TLR5 agonist); vaccine adjuvantAdjuvant50 ug
AV-7015-1Lipopolysaccharides (LPS) (Escherichia coli 0111:B4) vaccine adjuvantAdjuvant1 mg
AV-7015-10Lipopolysaccharides (LPS) (Escherichia coli 0111:B4) vaccine adjuvantAdjuvant10 mg
AV-7016-1Lipopolysaccharides (LPS) (Escherichia coli 0111:B4) vaccine adjuvant, ultrapure, TLR4 testedAdjuvant1 mg
AV-7016-5Lipopolysaccharides (LPS) (Escherichia coli 0111:B4) vaccine adjuvant, ultrapure, TLR4 testedAdjuvant5 mg
AV-7020-1Lipopolysaccharides (LPS) (Salmonella typhimurium) vaccine adjuvantAdjuvant1 mg
AV-7020-10Lipopolysaccharides (LPS) (Salmonella typhimurium) vaccine adjuvantAdjuvant10 mg
AV-7025-1Monophosphoryl lipid A (MPLA)-SM (S. enterica Minnesota, R595),vaccine adjuvantAdjuvant1 mg
AV-7025-5Monophosphoryl lipid A (MPLA)-SM (S. enterica Minnesota, 595),vaccine adjuvantAdjuvant5 mg
AV-7030-1Monophosphoryl lipid A (MPLA) (Synthetic, TLR4/Th1) vaccine adjuvantAdjuvant1 mg
AV-7030-5Monophosphoryl lipid A (MPLA) (Synthetic, TLR4/Th1) vaccine adjuvantAdjuvant5 mg
AV-7035-1MDP, muramyldipetide (Ac-muramyl-Ala-D-Glu-amide) Synthetic; vaccine adjuvantAdjuvant1 mg
AV-7035-5MDP, muramyldipetide (Ac-muramyl-Ala-D-Glu-amide) Synthetic; vaccine adjuvantAdjuvant5 mg
AV-7040-1Diphosphoryl Lipid A (E. coli K12 D31m4)Adjuvant1 mg
AV-7040-5Diphosphoryl Lipid A (E. coli K12 D31m4)Adjuvant5 mg
AV-7045-25Peptidoglycan (S. aureus); vaccine adjuvantAdjuvant25 mg
AV-7045-5Peptidoglycan (S. aureus); vaccine adjuvantAdjuvant5 mg
AV-8000-PK-1Synthetic Adjuvant Combo Pak-1 (contains 1 mg of Gardiquimod (#AV-8010), Imiquimod (#AV-8015) and 1 mg R848 (#AV-8020-1)Adjuvant1 pk
AV-8010-25Gardiquimod (TLR7 agonist/Imidazoquinoline), antigen gradeAdjuvant25 mg
AV-8010-5Gardiquimod (TLR7 agonist/Imidazoquinoline), antigen gradeAdjuvant5 mg
AV-8015-25Imiquimod (TLR7 agonist/Imidazoquinoline), antigen gradeAdjuvant25 mg
AV-8015-5Imiquimod (TLR7 agonist/Imidazoquinoline), antigen gradeAdjuvant5 mg
AV-8020-1Resiquimod (Imidazoquinoline compound)-TLR7/8 agonist, antigen gradeAdjuvant1 mg
AV-8020-5Resiquimod (Imidazoquinoline compound)-TLR7/8 agonist, antigen gradeAdjuvant5 mg
AV-9000-PK-2Synthetic Adjuvant Combo Pak-2 (contains 1 mg of Pam2csk4 (#AV-9020-1), 1 mg of Pam3csk4 (#AV-9025-1) and 1 mg of Poly(I:C) (#AV-9030)Adjuvant1 pk
AV-9010-1RWJ 21757 Synthetic vaccine adjuvantAdjuvant1 mg
AV-9010-5RWJ 21757 Synthetic vaccine adjuvantAdjuvant5 mg
AV-9015-2TDB (Trehalose-6,6-dibehenate) Synthetic vaccine adjuvantAdjuvant2 mg
AV-9020-1Pam2CSK4 vaccine adjuvant, unlabeledAdjuvant1 mg
AV-9020-BPam2CSK4 vaccine adjuvant; Biotin conjugateAdjuvant1 mg
AV-9020-B-100Pam2CSK4 vaccine adjuvant; Biotin conjugateAdjuvant100 ug
AV-9025-1Pam3CSK4 vaccine adjuvant, unlabeledAdjuvant1 mg
AV-9025-BPam3CSK4 vaccine adjuvant; Biotin labelledAdjuvant100 ug
AV-9025-FPam3CSK4 vaccine adjuvant; FITC labelledAdjuvant100 ug
AV-9030-10Poly(I:C) (Polyinosinic-Polycytidylic) SyntheticAdjuvant10 mg
AV-9030-50Poly(I:C) (Polyinosinic-Polycytidylic) SyntheticAdjuvant50 mg
AV-9105-25Tetanus Toxoid from C. tetani purified, vaccine gradeODNs/DNAs25 ug
AV-9110-10Recombinant purified tetani toxin Light-chain (Non toxic)Adjuvant10 ug
AV-9115-10Recombinant (P. fluorescens) purified tetani toxin C-terminal fragment (~52 Kda, >95% pure, low endotoxin)Adjuvant10 ug
AV-9120-500Purified Diphtheria Toxoid protein antigen gradeAdjuvant500 ug
AV-9125-100Purified CRM197 (Diphtheria Toxin mutant) protein vaccine gradeAdjuvant100 ug
AV-9135-1000Purified Cholera Toxin protein; vaccine gradeAdjuvant1 mg
AV-9135-500Purified Cholera Toxin protein; vaccine gradeAdjuvant500 ug
AV-9145-10Purified Pasteurella multocida Toxin (146 kda), vaccine gradeODNs/DNAs10 ug
AV-9150-10Purified Exotoxin A from P. aeruginosa, vaccine gradeAdjuvant100 ug
AV-9200-PK-1Bacterial endotoxins Combo Pak-1 (contains 25 ug Tetanus toxoid (#AV-9105-25); 100 ug Diphtheria Toxin (#AV-9120-25);Diphtheria Toxin and 500 ug cholera toxin (#AV-9135-25;)ODNs/DNAs1 pk
AV-9305-10Keyhole Limpet Hemocyanin (Megathura Crenulata)ODNs/DNAs10 mg
AV-9305-100Keyhole Limpet Hemocyanin (Megathura Crenulata)ODNs/DNAs100 mg
AV-9310-1000Chicken egg ovalbumin (Gal d 2) protein (ELISA, antigen, allergy grade)ODNs/DNAs1 g
AV-9315-1Ovalbumin peptide OVA (Gal d 2, 257-264) class I MHC moleculeODNs/DNAs1 mg
AV-9315-10Ovalbumin peptide OVA (Gal d 2, 257-264) class I MHC moleculeODNs/DNAs10 mg
AV-9320-1Ovalbumin peptide OVA (Gal d 2, 323-339) MHC class II peptideODNs/DNAs1 mg
AV-9320-10Ovalbumin peptide OVA (Gal d 2, 323-339) MHC class II peptideODNs/DNAs10 mg
CIODN-1Core-iODN-Class I-Murine TLR9 Antagonist, antigen gradeODNs/DNAs100 ug
EXA15-N-100Purified Exotoxin A from P. aeruginosaRec. Protein10 ug
GODN-1G-ODN Murine TLR9 antagonist-Antigen gradeODNs/DNAs200 ug
ODN-NT-1Neutral ODN control ODN without agonistic nor antagonistic activity antigen gradeODNs/DNAs100 ug
ODN-PK-1Mouse TLR9-agonist kit; contains 100 ug of ODN1585-1; ODN1826-1, ODN2395-1, and negative controls ODN1585-1NC; ODN1826-1-1NC, ODN2395-1NCODNs/DNAs1 pk
ODN-PK-2Human TLR9-agonist kit; contains 100 ug of ODN2006-1; ODN2216-1; ODN2395-1; and negative controls ODN2006-1NC; ODN2216-1NC; ODN2395-1NCODNs/DNAs1 pk
ODN-PK-3TLR9-antagonist kit; contains 100 ug of ODN2088-1; ODN4084-F; ODNINH-1; ODNINH-18; ONDTT-1.ODNs/DNAs1 pk
ODN-PK-4TLR9-A&C class agonist kit, Contains 100 ug of ODN1585-1; ODN2216-1; ODN2336-1;ODN 2395 and ODN M362; ODNDSL03ODNs/DNAs1 pk
ODN-PK-5TLR9-B class agonist kit, Contains 100 ug of - ODN1668-1; ODN1826;and ODN2006 - ODN BW006 - B class, human/mouse - ODN 2007 - B-class, bovine/porcine - ODN D-SL01ODNs/DNAs1 pk
ODN006-1ODNBW006 Type B CpG ODN structure feature at the 5' and A-type CpG ODN structure feature at the 3' endODNs/DNAs1 mg
ODN1585-1ODN 1585-Type A murine TLR9 agonist-Antigen gradeODNs/DNAs1 mg
ODN1585-1NCODN 1585-Type A murine TLR9 agonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN1585-5ODN 1585-ype A murine TLR9 agonist-Antigen gradeODNs/DNAs5 mg
ODN1585-5NCODN 1585-Type A murine TLR9 agonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN1585-BODN 1585-Type A murine TLR9 agonist Biotin Conjugate, antigen gradeODNs/DNAsCustom
ODN1585-FODN 1585-Type A murine TLR9 agonist FITC conjugate Antigen gradeODNs/DNAsCustom
ODN1668-1ODN 1668-Type B murine TLR9 Agonist-Antigen gradeODNs/DNAs1 mg
ODN1668-1NCODN 1668- Type B murine TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN1668-5ODN 1668-Type B murine TLR9 Agonist-Antigen gradeODNs/DNAs5 mg
ODN1668-5NCODN 1668- Type B murine TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN1668-BODN 1668 -Type B murine TLR9 Agonist biotin conjugate- Antigen gradeODNs/DNAsCustom
ODN1668-FODN 1668-Type B murine TLR9 Agonist FITC conjugate- Antigen gradeODNs/DNAsCustom
ODN1826-1ODN 1826- Type B murine TLR9 Agonist-antigen gradeODNs/DNAs1 mg
ODN1826-1NCODN 1826- Type B murine TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN1826-5ODN 1826- Type B murine TLR9 Agonist-antigen gradeODNs/DNAs5 mg
ODN1826-5NCODN 1826- Type B murine TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN1826-BODN 1826- Type B murine TLR9 Agonist Biotin conjugate, antigen gradeODNs/DNAsCustom
ODN1826-FODN 1826- Type B murine TLR9 Agonist FITC conjugate, antigen gradeODNs/DNAsCustom
ODN2006-1ODN 2006 -Type B-human TLR9 agonist-antigen gradeODNs/DNAs1 mg
ODN2006-1NCODN 2006- Type B human TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN2006-5ODN 2006 -Type B-human TLR9 agonist-antigen gradeODNs/DNAs5 mg
ODN2006-5NCODN 2006- Type B human TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN2006-BODN 2006 -Type B-human TLR9 agonist Biotin conjugate-antigen gradeODNs/DNAs50 ug
ODN2006-FODN 2006 -Type B-human TLR9 agonist FITC conjugate-antigen gradeODNs/DNAsCustom
ODN2007-1ODN 2007-Type B bovine/porcineTLR9 agonist-antigen gradeODNs/DNAs1 mg
ODN2007-1NCODN 2007- Type B bovine/porcine TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN2007-200ODN 2007-Type B bovine/porcineTLR9 agonist-antigen grade, 200 ugODNs/DNAs200 ug
ODN2007-5ODN 2007-Type B bovine/porcineTLR9 agonist-antigen gradeODNs/DNAs5 mg
ODN2007-5NCODN 2007- Type B bovine/porcine TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN2041-1ODN 2041-Non-CpG ODN. Invitro control for rabbit cells. Antigen gradeODNs/DNAs1 mg
ODN2088-1ODN 2088- Murine Class I TLR9 Antagonist.-antigen gradeODNs/DNAs1 mg
ODN2088-1NCODN 2088- Class I-Murine TLR9 Antagonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN2088-5ODN 2088- Murine Class I TLR9 Antagonist.-antigen gradeODNs/DNAs5 mg
ODN2088-5NCODN 2088- Class I-Murine TLR9 Antagonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN2216-1ODN 2216-Type A human TLR9 Agonist.-antigen gradeODNs/DNAs1 mg
ODN2216-1NCODN 2216- Type A human TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN2216-200ODN 2216-Type A human TLR9 Agonist.-antigen grade, 200ugODNs/DNAs200 ug
ODN2216-5ODN 2216-Type A human TLR9 Agonist.-antigen gradeODNs/DNAs5 mg
ODN2216-5NCODN 2216- Type A human TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN2216-BODN 2216-Type A human TLR9 Agonist Biotin conjugate-antigen gradeODNs/DNAsCustom
ODN2216-FODN 2216-Type A human TLR9 Agonist FITC conjugate-antigen gradeODNs/DNAsCustom
ODN2336-1ODN 2336- Type A human specific TLR 9 agonist-antigen gradeODNs/DNAs1 mg
ODN2336-1NCODN 2336- Type A human specific TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN2336-5ODN 2336- Type A human specific TLR 9 agonist-antigen gradeODNs/DNAs5 mg
ODN2336-5NCODN 2336- Type A human specific TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN2336-FODN 2336 -Type A human specific TLR 9 agonist-antigen gradeODNs/DNAsCustom
ODN2395-1ODN 2395-Type C human/murine TLR9 agonist-antigen gradeODNs/DNAs1 mg
ODN2395-1NCODN 2395- Type C human/ murine TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs1 mg
ODN2395-5ODN 2395-Type C human/murine TLR9 agonist-antigen gradeODNs/DNAs5 mg
ODN2395-5NCODN 2395- Type C human/ murine TLR9 Agonist (Negative Control), antigen gradeODNs/DNAs5 mg
ODN2395-FODN 2395-Type C human/murine TLR9 agonist FITC conjugate-antigen gradeODNs/DNAs50 ug
ODN4084F-1ODN 4084-Type B Inhibitory TLR9 Antagonist.-antigen gradeODNs/DNAs200 ug
ODN4084F-5ODN 4084-Type B Inhibitory TLR9 Antagonist.-antigen gradeODNs/DNAs5 mg
ODNDSL01-1Type C CpG ODN and a TLR9 agonist, antigen gradeODNs/DNAs200 µg
ODNDSL03-1Type B CpG ODN and a TLR9 agonist, antigen gradeODNs/DNAs200 µg
ODNIHN1-1ODN INH-1-Class R (restricted) inhibitory ODN-TLR 9 Antagonist-antigen gradeODNs/DNAs200 ug
ODNINH18-1ODN INH-18 class R (?restricted?) inhibitory ODN-TLR9 antagonist antigen gradeODNs/DNAs200 µg
ODNINH47-1ODN INH-47-Class R (restricted) inhibitory ODN TLR9 Antagonist-Palindromic variant of ODN INH-1-antigen gradeODNs/DNAs200 ug
ODNM362-1ODN M362-Type C human/murine TLR9 agonist-antigen grade-antigen gradeODNs/DNAs1 mg
ODNM362-1NCODN M362-Type C human/murine TLR9 agonist (negative control), antigen gradeODNs/DNAs1 mg
ODNM362-5ODN M362-Type C human/murine TLR9 agonist-antigen grade-antigen gradeODNs/DNAs5 mg
ODNM362-5NCODN M362-Type C human/murine TLR9 agonist (negative control), antigen gradeODNs/DNAs5 mg
ODNM362-BODN M362-Type C human/murine TLR9 agonist Biotin conjugate-antigen gradeODNs/DNAsCustom
ODNM362-FODN M362-Type C human/murine TLR9 agonist FITC conjugate-antigen gradeODNs/DNAsCustom
ODNTT-1ODN TTAGGG-Class G Human-TLR 9 Antagonist, antigen gradeODNs/DNAs1 mg
ODNTT-1NCODN TTAGGG-Class G Human-TLR 9 Antagonist, antigen gradeODNs/DNAs1 mg
PDNA15-N-100Baceterial Plasmid dsDNA, >95% pureODNs/DNAs100 ug
R848-1Resiquimod (Imidazoquinoline compound)-TLR7/8 agonist, antigen gradeODNs/DNAs1 mg
R848-5Resiquimod (Imidazoquinoline compound)-TLR7/8 agonist, antigen gradeODNs/DNAs5 mg
RP-343Recombinant (E.Coli) Anti-Tetanus Toxoid scFv IgGAntibodies10 ug
SIODN-1Inhibitory iODN- class I/II hybrid, may also affect TLR7 and TLR8 signaling.ODNs/DNAs100 ug
AV-1000-PK-1Alum Gel Combo, Trial Pak-1 (Contains 10 ml each of Alhydrogel, Adjuphos, and Calcium Phosphate gels) 1 pk
AV-1010-100Alhydrogel 2%, Vaccine adjuvant, FDA Approved 100 ml
AV-1010-50Alhydrogel 2%, Vaccine adjuvant, FDA Approved 50 ml